nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CYCS—pineal body—endogenous depression	0.0494	0.0853	CbGeAlD
Minocycline—IL1B—Serotonin Transporter Activity—TPH2—endogenous depression	0.03	0.0714	CbGpPWpGaD
Minocycline—IL1B—Serotonin Transporter Activity—SLC6A4—endogenous depression	0.024	0.0571	CbGpPWpGaD
Minocycline—IL1B—Serotonin Transporter Activity—MAOA—endogenous depression	0.0181	0.0429	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—MMP16—endogenous depression	0.016	0.0381	CbGpPWpGaD
Minocycline—CASP1—forebrain—endogenous depression	0.0154	0.0267	CbGeAlD
Minocycline—CYCS—brainstem—endogenous depression	0.0154	0.0266	CbGeAlD
Minocycline—MMP9—Activation of Matrix Metalloproteinases—MMP16—endogenous depression	0.0152	0.0362	CbGpPWpGaD
Minocycline—CYCS—forebrain—endogenous depression	0.0149	0.0257	CbGeAlD
Minocycline—CASP3—brainstem—endogenous depression	0.0132	0.0228	CbGeAlD
Minocycline—CASP1—cardiovascular system—endogenous depression	0.0131	0.0225	CbGeAlD
Minocycline—IL1B—Monoamine Transport—TPH2—endogenous depression	0.0128	0.0304	CbGpPWpGaD
Minocycline—CASP3—forebrain—endogenous depression	0.0127	0.022	CbGeAlD
Minocycline—CYCS—cardiovascular system—endogenous depression	0.0126	0.0217	CbGeAlD
Minocycline—IL1B—IL27-mediated signaling events—GATA3—endogenous depression	0.0121	0.0287	CbGpPWpGaD
Minocycline—CASP3—adrenal cortex—endogenous depression	0.0118	0.0204	CbGeAlD
Minocycline—CASP1—pituitary gland—endogenous depression	0.0116	0.02	CbGeAlD
Minocycline—CASP3—cardiovascular system—endogenous depression	0.0108	0.0186	CbGeAlD
Minocycline—IL1B—brainstem—endogenous depression	0.0105	0.0182	CbGeAlD
Minocycline—CASP1—adrenal gland—endogenous depression	0.0103	0.0178	CbGeAlD
Minocycline—IL1B—Monoamine Transport—SLC6A4—endogenous depression	0.0102	0.0243	CbGpPWpGaD
Minocycline—CASP1—midbrain—endogenous depression	0.0102	0.0176	CbGeAlD
Minocycline—IL1B—forebrain—endogenous depression	0.0102	0.0176	CbGeAlD
Minocycline—CASP1—thyroid gland—endogenous depression	0.00997	0.0172	CbGeAlD
Minocycline—CYCS—adrenal gland—endogenous depression	0.00994	0.0172	CbGeAlD
Minocycline—CYCS—midbrain—endogenous depression	0.00982	0.0169	CbGeAlD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP16—endogenous depression	0.00967	0.023	CbGpPWpGaD
Minocycline—CYCS—thyroid gland—endogenous depression	0.0096	0.0166	CbGeAlD
Minocycline—CASP3—pituitary gland—endogenous depression	0.00954	0.0165	CbGeAlD
Minocycline—VEGFA—adrenal cortex—endogenous depression	0.00927	0.016	CbGeAlD
Minocycline—CASP1—endocrine gland—endogenous depression	0.00896	0.0155	CbGeAlD
Minocycline—CYCS—endocrine gland—endogenous depression	0.00862	0.0149	CbGeAlD
Minocycline—IL1B—cardiovascular system—endogenous depression	0.0086	0.0149	CbGeAlD
Minocycline—CASP3—adrenal gland—endogenous depression	0.00852	0.0147	CbGeAlD
Minocycline—CASP1—nervous system—endogenous depression	0.00839	0.0145	CbGeAlD
Minocycline—CASP3—thyroid gland—endogenous depression	0.00822	0.0142	CbGeAlD
Minocycline—IL1B—Cytokines and Inflammatory Response—IL10—endogenous depression	0.00811	0.0193	CbGpPWpGaD
Minocycline—CASP1—central nervous system—endogenous depression	0.00807	0.0139	CbGeAlD
Minocycline—CYCS—nervous system—endogenous depression	0.00807	0.0139	CbGeAlD
Minocycline—SLC22A7—Fluoropyrimidine Activity—DPYD—endogenous depression	0.0079	0.0188	CbGpPWpGaD
Minocycline—CASP3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—endogenous depression	0.0079	0.0188	CbGpPWpGaD
Minocycline—CASP1—cerebellum—endogenous depression	0.00789	0.0136	CbGeAlD
Minocycline—CYCS—central nervous system—endogenous depression	0.00777	0.0134	CbGeAlD
Minocycline—CYCS—Alzheimers Disease—CACNA1C—endogenous depression	0.00777	0.0185	CbGpPWpGaD
Minocycline—IL1B—pituitary gland—endogenous depression	0.00762	0.0131	CbGeAlD
Minocycline—CYCS—cerebellum—endogenous depression	0.0076	0.0131	CbGeAlD
Minocycline—VEGFA—pituitary gland—endogenous depression	0.00749	0.0129	CbGeAlD
Minocycline—CASP3—endocrine gland—endogenous depression	0.00739	0.0128	CbGeAlD
Minocycline—MMP9—cardiovascular system—endogenous depression	0.00717	0.0124	CbGeAlD
Minocycline—CASP3—nervous system—endogenous depression	0.00691	0.0119	CbGeAlD
Minocycline—IL1B—adrenal gland—endogenous depression	0.00681	0.0117	CbGeAlD
Minocycline—IL1B—midbrain—endogenous depression	0.00672	0.0116	CbGeAlD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP16—endogenous depression	0.00671	0.0159	CbGpPWpGaD
Minocycline—VEGFA—adrenal gland—endogenous depression	0.00669	0.0116	CbGeAlD
Minocycline—CASP3—central nervous system—endogenous depression	0.00666	0.0115	CbGeAlD
Minocycline—IL1B—thyroid gland—endogenous depression	0.00657	0.0113	CbGeAlD
Minocycline—CASP3—cerebellum—endogenous depression	0.00651	0.0112	CbGeAlD
Minocycline—VEGFA—thyroid gland—endogenous depression	0.00646	0.0111	CbGeAlD
Minocycline—CASP1—brain—endogenous depression	0.00641	0.0111	CbGeAlD
Minocycline—CASP3—Alzheimers Disease—CACNA1C—endogenous depression	0.00627	0.0149	CbGpPWpGaD
Minocycline—CYCS—brain—endogenous depression	0.00617	0.0106	CbGeAlD
Minocycline—CASP3—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—endogenous depression	0.00592	0.0141	CbGpPWpGaD
Minocycline—IL1B—endocrine gland—endogenous depression	0.0059	0.0102	CbGeAlD
Minocycline—IL1B—Alzheimers Disease—CACNA1C—endogenous depression	0.00567	0.0135	CbGpPWpGaD
Minocycline—MMP9—adrenal gland—endogenous depression	0.00567	0.00979	CbGeAlD
Minocycline—ALOX5—cardiovascular system—endogenous depression	0.00567	0.00978	CbGeAlD
Minocycline—IL1B—nervous system—endogenous depression	0.00552	0.00953	CbGeAlD
Minocycline—CYCS—p75(NTR)-mediated signaling—BDNF—endogenous depression	0.00549	0.0131	CbGpPWpGaD
Minocycline—IL1B—central nervous system—endogenous depression	0.00532	0.00918	CbGeAlD
Minocycline—CASP3—brain—endogenous depression	0.00528	0.00912	CbGeAlD
Minocycline—CASP3—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00525	0.0125	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—CRH—endogenous depression	0.00522	0.0124	CbGpPWpGaD
Minocycline—VEGFA—cerebellum—endogenous depression	0.00511	0.00882	CbGeAlD
Minocycline—MMP9—endocrine gland—endogenous depression	0.00492	0.00849	CbGeAlD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.00489	0.0116	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00475	0.0113	CbGpPWpGaD
Minocycline—SLC22A11—endocrine gland—endogenous depression	0.00466	0.00805	CbGeAlD
Minocycline—MMP9—nervous system—endogenous depression	0.0046	0.00795	CbGeAlD
Minocycline—SLC22A7—endocrine gland—endogenous depression	0.00455	0.00785	CbGeAlD
Minocycline—ALOX5—adrenal gland—endogenous depression	0.00448	0.00774	CbGeAlD
Minocycline—IL1B—TCR Signaling Pathway—GATA3—endogenous depression	0.00447	0.0106	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—BDNF—endogenous depression	0.00443	0.0105	CbGpPWpGaD
Minocycline—MMP9—central nervous system—endogenous depression	0.00443	0.00765	CbGeAlD
Minocycline—ALOX5—thyroid gland—endogenous depression	0.00433	0.00747	CbGeAlD
Minocycline—IL1B—brain—endogenous depression	0.00422	0.00729	CbGeAlD
Minocycline—VEGFA—brain—endogenous depression	0.00415	0.00717	CbGeAlD
Minocycline—CASP3—Extracellular matrix organization—MMP16—endogenous depression	0.00405	0.00963	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.00398	0.00945	CbGpPWpGaD
Minocycline—ALOX5—endocrine gland—endogenous depression	0.00389	0.00671	CbGeAlD
Minocycline—CASP3—Allograft Rejection—IL10—endogenous depression	0.0038	0.00903	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—ADM—endogenous depression	0.00371	0.00882	CbGpPWpGaD
Minocycline—ALOX5—nervous system—endogenous depression	0.00364	0.00628	CbGeAlD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—WASF2—endogenous depression	0.00363	0.00864	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.0036	0.00855	CbGpPWpGaD
Minocycline—MMP9—brain—endogenous depression	0.00352	0.00607	CbGeAlD
Minocycline—ALOX5—central nervous system—endogenous depression	0.0035	0.00605	CbGeAlD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—WASF1—endogenous depression	0.00348	0.00828	CbGpPWpGaD
Minocycline—IL1B—Allograft Rejection—IL10—endogenous depression	0.00344	0.00817	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—WASF2—endogenous depression	0.00343	0.00815	CbGpPWpGaD
Minocycline—ALOX5—cerebellum—endogenous depression	0.00342	0.00591	CbGeAlD
Minocycline—CASP3—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00329	0.00782	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—WASF1—endogenous depression	0.00329	0.00782	CbGpPWpGaD
Minocycline—SLC22A7—brain—endogenous depression	0.00326	0.00562	CbGeAlD
Minocycline—CASP3—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00318	0.00755	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00318	0.00755	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TPH1—endogenous depression	0.00316	0.00751	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—BDNF—endogenous depression	0.00315	0.00749	CbGpPWpGaD
Minocycline—SLC22A6—brain—endogenous depression	0.00314	0.00542	CbGeAlD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—OXT—endogenous depression	0.00311	0.00739	CbGpPWpGaD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—CRH—endogenous depression	0.00311	0.00739	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—BDNF—endogenous depression	0.00307	0.00729	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00298	0.00708	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—IL10—endogenous depression	0.0029	0.0069	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—BDNF—endogenous depression	0.00289	0.00686	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00288	0.00684	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00288	0.00684	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP16—endogenous depression	0.00281	0.00668	CbGpPWpGaD
Minocycline—ALOX5—brain—endogenous depression	0.00278	0.0048	CbGeAlD
Minocycline—MMP9—AP-1 transcription factor network—NR3C1—endogenous depression	0.00269	0.00639	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—BDNF—endogenous depression	0.00261	0.00621	CbGpPWpGaD
Minocycline—SLC22A8—nervous system—endogenous depression	0.00246	0.00425	CbGeAlD
Minocycline—CASP3—BDNF signaling pathway—BDNF—endogenous depression	0.00246	0.00585	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—TPH2—endogenous depression	0.0024	0.00569	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00239	0.00569	CbGpPWpGaD
Minocycline—CASP3—Corticotropin-releasing hormone—POMC—endogenous depression	0.00238	0.00565	CbGpPWpGaD
Minocycline—SLC22A8—central nervous system—endogenous depression	0.00237	0.00409	CbGeAlD
Minocycline—CASP3—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00231	0.00549	CbGpPWpGaD
Minocycline—VEGFA—Allograft Rejection—IL10—endogenous depression	0.00229	0.00544	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—WASF2—endogenous depression	0.00227	0.00539	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—IL10—endogenous depression	0.0022	0.00524	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ANK3—endogenous depression	0.00218	0.00519	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—WASF1—endogenous depression	0.00217	0.00517	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—BDNF—endogenous depression	0.00217	0.00517	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00216	0.00515	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00209	0.00496	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00204	0.00485	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—BDNF—endogenous depression	0.002	0.00476	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—IL10—endogenous depression	0.00199	0.00474	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—HTR1A—endogenous depression	0.00198	0.00471	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—BDNF—endogenous depression	0.00197	0.00468	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.00196	0.00467	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00195	0.00463	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—GATA3—endogenous depression	0.00192	0.00455	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—SLC6A4—endogenous depression	0.00192	0.00455	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ANK3—endogenous depression	0.00189	0.0045	CbGpPWpGaD
Minocycline—SLC22A8—brain—endogenous depression	0.00188	0.00325	CbGeAlD
Minocycline—IL1B—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00184	0.00439	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00176	0.00419	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ANK3—endogenous depression	0.00156	0.0037	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—CACNB2—endogenous depression	0.00154	0.00366	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—MAOA—endogenous depression	0.00144	0.00343	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—CACNA1C—endogenous depression	0.00141	0.00334	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—BDNF—endogenous depression	0.00139	0.00331	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ANK3—endogenous depression	0.00135	0.00321	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CACNB2—endogenous depression	0.00134	0.00317	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—IL10—endogenous depression	0.00133	0.00316	CbGpPWpGaD
Minocycline—CASP1—Immune System—WASF2—endogenous depression	0.00132	0.00314	CbGpPWpGaD
Minocycline—CASP1—Immune System—WASF1—endogenous depression	0.00127	0.00301	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NR3C1—endogenous depression	0.00123	0.00292	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—CACNA1C—endogenous depression	0.00122	0.0029	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	0.00118	0.00281	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—HTR2A—endogenous depression	0.00117	0.00279	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CACNB2—endogenous depression	0.0011	0.00261	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TPH1—endogenous depression	0.00103	0.00244	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—CACNA1C—endogenous depression	0.001	0.00239	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CACNB2—endogenous depression	0.000953	0.00226	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—CACNA1C—endogenous depression	0.000871	0.00207	CbGpPWpGaD
Minocycline—IL1B—Immune System—WASF2—endogenous depression	0.000826	0.00196	CbGpPWpGaD
Minocycline—IL1B—Immune System—WASF1—endogenous depression	0.000792	0.00188	CbGpPWpGaD
Minocycline—CYCS—Metabolism—TPH2—endogenous depression	0.000779	0.00185	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CACNB2—endogenous depression	0.000779	0.00185	CbGpPWpGaD
Minocycline—CYCS—Metabolism—DPYD—endogenous depression	0.000767	0.00182	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—GATA3—endogenous depression	0.000747	0.00178	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CACNA1C—endogenous depression	0.000713	0.00169	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TPH1—endogenous depression	0.000634	0.00151	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CYP2D6—endogenous depression	0.000623	0.00148	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WASF2—endogenous depression	0.00059	0.0014	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—WASF1—endogenous depression	0.000566	0.00134	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADM—endogenous depression	0.00054	0.00128	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—TPH2—endogenous depression	0.00048	0.00114	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CACNB2—endogenous depression	0.00048	0.00114	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—DPYD—endogenous depression	0.000472	0.00112	CbGpPWpGaD
Minocycline—CYCS—Metabolism—COMT—endogenous depression	0.000472	0.00112	CbGpPWpGaD
Minocycline—CYCS—Metabolism—MAOA—endogenous depression	0.000469	0.00111	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CRH—endogenous depression	0.000452	0.00107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—OXT—endogenous depression	0.000452	0.00107	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CACNA1C—endogenous depression	0.000439	0.00104	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR1A—endogenous depression	0.000435	0.00103	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—POMC—endogenous depression	0.000422	0.001	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2C—endogenous depression	0.00042	0.000999	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WASF2—endogenous depression	0.00041	0.000973	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—WASF1—endogenous depression	0.000393	0.000933	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CYP2D6—endogenous depression	0.000384	0.000913	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADM—endogenous depression	0.000375	0.00089	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR7—endogenous depression	0.000368	0.000875	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WASF2—endogenous depression	0.000355	0.000845	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—WASF1—endogenous depression	0.000341	0.00081	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADM—endogenous depression	0.000325	0.000773	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CRH—endogenous depression	0.000314	0.000746	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—OXT—endogenous depression	0.000314	0.000746	CbGpPWpGaD
Minocycline—CYCS—Metabolism—POMC—endogenous depression	0.000305	0.000725	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR1A—endogenous depression	0.000302	0.000718	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2C—endogenous depression	0.000292	0.000694	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—COMT—endogenous depression	0.000291	0.000692	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MAOA—endogenous depression	0.000289	0.000687	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—OXT—endogenous depression	0.000272	0.000648	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CRH—endogenous depression	0.000272	0.000648	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR1A—endogenous depression	0.000262	0.000623	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—endogenous depression	0.000258	0.000613	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR7—endogenous depression	0.000256	0.000608	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2C—endogenous depression	0.000253	0.000602	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR7—endogenous depression	0.000222	0.000527	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—endogenous depression	0.000206	0.00049	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—endogenous depression	0.000188	0.000447	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—endogenous depression	0.000179	0.000425	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—endogenous depression	0.000155	0.000369	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—endogenous depression	0.000143	0.00034	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—endogenous depression	0.000124	0.000295	CbGpPWpGaD
